Click4Assistance UK Live Chat Software
Helpline01322 619898

IMPORTANT NOTIFICATION: UPDATE: Availability of EpiPen® (Senior) 0.3mg Adrenaline Auto-Injector

Dear Allergy UK,

Due to manufacturing delays from our contract manufacturer, Meridian Medical Technologies, a Pfizer company, there are intermittent supply constraints of EpiPen® 0.3mg (Senior) Adrenaline Auto-Injector in the UK. At this time, there are no supply constraints of EpiPenJr® 0.15mg Adrenaline Auto-Injectors.

Our first priority is to ensure patients at risk for a potentially life-threatening allergic reaction (anaphylaxis) have access to adrenaline auto-injector products. Mylan is working closely with Pfizer to manage supply carefully to avoid long-term supply shortages. Pfizer anticipates that production rates will increase over the coming months; however, at this time, cannot commit to a specific time for when the supply constraint will be fully resolved.

To further assist in the stock management of EpiPen® 0.3mg (Senior), pharmacies are allocating stock on a prescription-only basis and are placing orders for up to a maximum of two EpiPen® 0.3mg (Senior) Auto-Injectors per prescription.

Mylan is unable to make any specific treatment recommendation to individual patients. Patients should speak to their healthcare provider for appropriate actions to be taken. Please note, when validating the expiry date of an adrenaline auto-injector, the product expires on the last day of the month indicated. For example, if it expires in March, it remains valid (not expired) until March 31.

We are confident in the safety and efficacy of the EpiPen® products being produced at the site and are working closely with Pfizer to alleviate the situation and achieve a steady state of supply as expeditiously as possible.

If you require additional information or have any questions, please contact +44(0) 1707 853 100.

Jean-Yves Brault
Country Manager

Share this news story